4.3 Review

Host-parasite dynamics in Chagas disease from systemic to hyper-local scales

期刊

PARASITE IMMUNOLOGY
卷 43, 期 2, 页码 -

出版社

WILEY
DOI: 10.1111/pim.12786

关键词

cell mediated immunity; Chagas disease; humoral immunity; in vivo imaging; innate immunity; trypanosomes

资金

  1. Medical Research Council [MR/N013638/1, MR/R021430/1]
  2. MRC [MR/R021430/1] Funding Source: UKRI

向作者/读者索取更多资源

Trypanosoma cruzi is a versatile parasite that can parasitize almost any nucleated cell type and naturally infects a variety of mammal species, causing Chagas disease. While a large number of people are infected, around two thirds of them remain long-term asymptomatic carriers. Clinical outcomes of chronic infections depend on the interactions between host and parasite.
Trypanosoma cruziis a remarkably versatile parasite. It can parasitize almost any nucleated cell type and naturally infects hundreds of mammal species across much of the Americas. In humans, it is the cause of Chagas disease, a set of mainly chronic conditions predominantly affecting the heart and gastrointestinal tract, which can progress to become life threatening. Yet around two thirds of infected people are long-term asymptomatic carriers. Clinical outcomes depend on many factors, but the central determinant is the nature of the host-parasite interactions that play out over the years of chronic infection in diverse tissue environments. In this review, we aim to integrate recent developments in the understanding of the spatial and temporal dynamics ofT. cruziinfections with established and emerging concepts in host immune responses in the corresponding phases and tissues.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery

Lorna M. MacLean, John Thomas, Michael D. Lewis, Ignacio Cotillo, David W. Gray, Manu De Rycker

PLOS NEGLECTED TROPICAL DISEASES (2018)

Correction Immunology

c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells (vol 19, pg 497, 2018)

Leona Gabrysova, Marisol Alvarez-Martinez, Raphaelle Luisier, Luke S. Cox, Jan Sodenkamp, Caroline Hosking, Damian Perez-Mazliah, Charlotte Whicher, Yashaswini Kannan, Krzysztof Potempa, Xuemei Wu, Leena Bhaw, Hagen Wende, Michael H. Sieweke, Greg Elgar, Mark Wilson, James Briscoe, Vicki Metzis, Jean Langhorne, Nicholas M. Luscombe, Anne O'Garra

NATURE IMMUNOLOGY (2019)

Article Endocrinology & Metabolism

Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease

K. Hennig, J. Abi-Ghanem, A. Bunescu, X. Meniche, E. Biliaut, A. D. Ouattara, M. D. Lewis, J. M. Kelly, S. Braillard, G. Courtemanche, E. Chatelain, F. Bequet

METABOLOMICS (2019)

Review Immunology

B-cell memory in malaria: Myths and realities

Damian Perez-Mazliah, Francis M. Ndungu, Racheal Aye, Jean Langhorne

IMMUNOLOGICAL REVIEWS (2020)

Article Infectious Diseases

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection

Martin C. Taylor, Alexander Ward, Francisco Olmo, Shiromani Jayawardhana, Amanda F. Francisco, Michael D. Lewis, John M. Kelly

PLOS NEGLECTED TROPICAL DISEASES (2020)

Review Biochemistry & Molecular Biology

Challenges in Chagas Disease Drug Development

Amanda F. Francisco, Shiromani Jayawardhana, Francisco Olmo, Michael D. Lewis, Shane R. Wilkinson, Martin C. Taylor, John M. Kelly

MOLECULES (2020)

Review Pharmacology & Pharmacy

Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug Activity

Martin C. Taylor, Alexander Ward, Francisco Olmo, Amanda F. Francisco, Shiromani Jayawardhana, Fernanda C. Costa, Michael D. Lewis, John M. Kelly

Summary: Chagas disease is caused by infection with the trypanosomatid parasite Trypanosoma cruzi. Challenges in developing new drugs have been posed by the long term and complex nature of the condition and limited understanding of parasite biology. The development of noninvasive, highly sensitive bioluminescence imaging procedures based on red-shifted luciferase-expressing parasites has greatly improved infection monitoring and driven drug development.

CURRENT PHARMACEUTICAL DESIGN (2021)

Article Genetics & Heredity

Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity

Philipp Schwabl, Jalil Maiguashca Sanchez, Jaime A. Costales, Sofia Ocana-Mayorga, Maikell Segovia, Hernan J. Carrasco, Carolina Hernandez, Juan David Ramirez, Michael D. Lewis, Mario J. Grijalva, Martin S. Llewellyn

PLOS GENETICS (2020)

Article Immunology

Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi

Carlos Talavera-Lopez, Louisa A. Messenger, Michael D. Lewis, Matthew Yeo, Joao Luis Reis-Cunha, Gabriel Machado Matos, Daniella C. Bartholomeu, Jose E. Calzada, Azael Saldana, Juan David Ramirez, Felipe Guhl, Sofia Ocana-Mayorga, Jaime A. Costales, Rodion Gorchakov, Kathryn Jones, Melissa S. Nolan, Santuza M. R. Teixeira, Hernan Jose Carrasco, Maria Elena Bottazzi, Peter J. Hotez, Kristy O. Murray, Mario J. Grijalva, Barbara Burleigh, Edmundo C. Grisard, Michael A. Miles, Bjorn Andersson

Summary: Trypanosoma cruzi, the causative agent of Chagas disease, has a complex and highly plastic genome, with surface molecules playing key roles in cell invasion, immune evasion, and pathogenesis. The genome assembly of the reference genome sequence for T. cruzi clade I has shed light on the unusual distribution and recombination mechanism of surface molecule genes, providing new insights into the population structure of T. cruzi.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale

Archie A. Khan, Harry C. Langston, Fernanda C. Costa, Francisco Olmo, Martin C. Taylor, Conor J. McCann, John M. Kelly, Michael D. Lewis

Summary: The study identified specific combinations of parasites and mice models that mimic symptoms of digestive Chagas disease in humans, particularly in the colon. By using genetically modified parasites, the research was able to track infection foci and nerve system lesions, highlighting the potential role of chronic infection and inflammation in the development of the disease.

PLOS PATHOGENS (2021)

Article Immunology

Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon

Alexander Ward, Michael D. Lewis, Martin C. Taylor, John M. Kelly

Summary: This study systematically analyzed the immunological microenvironments of parasitized cells in the mouse colon and found that incomplete recruitment of T cells to colonic infection foci allows the occurrence of repeated cycles of parasite replication and differentiation, leading to chronic infections.

INFECTION AND IMMUNITY (2022)

Article Biology

Microevolution of Trypanosoma cruzi reveals hybridization and clonal mechanisms driving rapid genome diversification

Gabriel Machado Matos, Michael D. Lewis, Carlos Talavera-Lopez, Matthew Yeo, Edmundo C. Grisard, Louisa A. Messenger, Michael Miles, Bjorn Andersson

Summary: The presence of genetic exchange in Trypanosoma cruzi has been controversial. Field studies and laboratory experiments have shown the existence of hybrids and hybrid progeny. Hybrid formation initially results in tetraploid parasites, but the progeny genomes gradually erode towards triploidy. However, elevated copy number is observed at several core housekeeping loci, indicating potential for adaptive evolution.
Article Biochemistry & Molecular Biology

Impact of Visceral Leishmaniasis on Local Organ Metabolism in Hamsters

Mahbobeh Lesani, Camil Gosmanov, Andrea Paun, Michael D. Lewis, Laura-Isobel Mccall

Summary: This study identified metabolites commonly impacted by Leishmania donovani infection across organs, including glycerophospholipids, ceramides, acylcarnitines, peptides, purines and amino acids. The comparison showed a greater overlap of perturbed metabolites between spleen and liver, in accordance with VL symptoms and parasite tropism.

METABOLITES (2022)

暂无数据